ACTRN12620000740998尚未招募未知
A Randomised Controlled Trial of Early Prone Positioning to Improve Oxygenation in Non-Intubated Adults Admitted to Intensive Care with COVID-19
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit(—)
- 性别
- All
入选标准
- •*Adults, over the age of 18
- •*COVID-19 Diagnosis Confirmed – either by PCR or as per any unit policy changes that may be applied during the enrolment period
- •*Admitted to Intensive Care
- •*Any severity of disease (As defined by National COVID 19 Clinical Evidence Taskforce Australian Guidelines for the clinical care of people with COVID-19 assessable at https://covid19evidence.net.au ). For patients with severe disease, the treating intensivist must be consulted prior to randomisation (see exclusion criterion #2)
- •*Willing and able to tolerate prone positioning (A pre-enrollment screening test to ensure they can tolerate the position and can maneuver into & out of the prone position with minimal assistance from their usual care staff only. )
- •*Prior informed consent has been obtained from the patient
排除标准
- •* Intubated, or expected to be intubated in the next 12 hours
- •* Non Intubated patients with severe disease where the treating intensivist (or an intensivist who is not a study investigator) has any safety concerns regarding the use of prone positioning
- •*Previously intubated for COVID-19, or in the recovery phase of their illness.
- •*Current (or expected) treatment limits such as ‘not for CPR’ or end-of-life care orders
- •*If in the judgment of the treating clinical team there is any other medical condition present which may reduce the safety of the prone positioning. Examples would include pregnancy, concurrent spinal precautions, severe cervical spine arthritis.
研究者
相似试验
进行中(未招募)
1 期
A Randomised Controlled Trial of Early Intervention in Patients HospItalised with COVID-19: Favipiravir verses HydroxycholorquiNe & Azithromycin & Zinc vErsEs Standard CaReCOVID-19 InfectionMedDRA version: 20.0Level: LLTClassification code 10051905Term: Coronavirus infectionSystem Organ Class: 100000004862EUCTR2020-001449-38-GBChelsea and Westminster Hospital NHS Foundation Trust450
已完成
不适用
A Randomized Placebo-controlled Trial of an Early Interventional Treatment with Mometasone Furoate Nasal Spray in Japanese Cedar/Cypress PollinosisJapanese cedar/cypress pollinosisJPRN-UMIN000005985Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences50
进行中(未招募)
Unknown
Early Positive Approaches to Support (E-PAtS) for families of young children with intellectual disability: a randomised controlled trialIntellectual disabilityMental and Behavioural DisordersISRCTN11192967niversity of Kent594
已完成
2 期
A randomized controlled trial on the effect of pre-thickened oral nutritional supplements on nutritional status of nursing home residents with oropharyngeal dysphagia and (at risk of) malnutritioNL-OMON48281niversiteit Maastricht156
尚未招募
4 期
The study of pain following mesh repair of abdominal wall hernias.CTRI/2024/07/070836ady Hardinge Medical College New Delhi
